4 monahans Part of the SUMER 'Group MUSGROVE LEUKAEMIC GROUP SOMERSET Raising funds for the benefit of Patients in Somerset UNAUDITED FINANCIAL STATEMEIYTS FOR THE YEAR ENDED 28 FEBRUARY 2025 REGISTERED CHAIUTY NUMBER 1036580
MUSGROVE LEUKAEMIC GROUP SOMERSEI T Raising funds for the benefit of Patients in Somerset TRUSTEES ANNUAL RKPORT FOR THE YEAR NDID 28 Fll4 BRUARY 2025 I FLRENCL AND ADIIqINISTRATION DETAILS Charity name.. Registered Charity number: Charity's principal address: Musgrove Leukaen]ic Group Somerset 1036580 16 Durleigh Road BRIDGWATER Somerset TA6 7FIR Trustees: Mrs Patricia Reed (Chairperson) Miss Jane Allin (Secretary) Mrs Maureen Hudson Mrs Margaret Smith Mr Bernard Reed (Treasurer) Mrs Pat Cornish Mr David Edwards Professional Adviso Bankers: National Westminster Bank plc 26127 Fore Street TAUNTON Somerset Independent Examiner: Monahans Chartered Accountants th 6 Floor Ihitefriars Lewins Mead BRISTOL BSI 2NT STRUCTURE GOVERNANCE AND MANAGLMEI NT Musgrove Leukaemic Group Somerset is a registered charity and has been constituted as an unincorporated association govei'ned by a formal constitLition, A copy of the constitution may be obtained on application to the Secretary. Trustees are elected at each Annual General Meeting biit retiring Trustees are eligible for re- election. The Officers may hold office until retirement or by rernoval at an Annual General Meeting. Co-opted Trustees nyay be appointed by the Commiltee at any time and generally have special l(nowledge or experience with leukaemia or related conditions. They may serve for such period as decided by the Committee or by their retirement,
MUSGROVE LEUKAEMIC GROUP SOMERSE4 T Raising funds for the benefit of Patients in Somerset TRUSTEES AIYNUAL REPORT FOR THL YEAR ENDED 28 FKBRUARY 2025 (continued) OBJECTIVES AND ACTIVITIE< S The Charity's Objectives and aclivttiesfor the Public Benefit The objects of the Group are to relieve persons suffering from Leukaemia and associated conditions by assisting and funding the treatments and welfare of such peOnS at Musgrove Park Hospital, Taunton Somerset or any other area authorised by the medical staff. The Group carries out these objects by: Sponsoring the medical staff that are considered key by the Somerset NHS Foundation Trust to maintaining Musgrove Parlc Hospital as a centre for the treatment of Leukaemia and other related diseases. The grants made to nursing staff for training are in an aspect which when complcted will enhance the experience of Leulcaemia patients whilst receiving treatment 'for Leukaemia and other related diseases. The purchasc of cquipment and furniture is nde following recommendations from the medical staff with a view to improving the quality of the treatment and the emotional and physical well- being of both suffers and relatives. Churtsy Organisatlon dnd Hlstory The Musgrove Leukaemic Group Somerset was launched in 1978 and is run completely by unpaid volunteers who absorb all their own personal expenses. There are no paid Officers and overheads are kept to an absolute minimum thercby cnsuring tbat most of the funds raised goes to the Haematology Unit at Musgrove Park Hospital, Taunton. The hospital has become a major centre in the South West for the diagnosis and treatment of leukaemia and related blood disorders. In general the aims of the Group are as follows: To maintain Musgrove Park 14ospital as a major centre for the diagnosis and treatsnent of l¢ukaemia and related blood disorders by the most up-to-date techniques, ii) To keep the public inforn]ed on progress being made on the diagnosis and treatment of these diseases. The Group meets regularly in Bridgwater and Taunton.
MUSGROVE LEUKAEMIC GROUP SOMERSET Raising funds for the benefit of Patients in Somerset TRUSTE1 S ANNUAL REPORT FOR T{ YEAR ENDED 28 FEBRUARY 2025 (continued) Policy is discussed at both Group and Committee meetings, but the Cornmittee has the duty to manage the Group and the power to ultimately make executive decisions. The Group has area representatives covering Somerset at Bridgwater, Burnham on Sea, Chard and Ilminster, Minchcad, Taunton, and Wellington. The area representatives act as local contacts organising events and visiting various businesses, people or other organisations as required. In turn they report back to Group meetings on a regular basis, ACHIEV1 MENTS AND PERFORMANC Chairperson's Report I reported last year that an ambulatory room had been established in Ward 9 and the Group were funding various pieces of equipment, The facility has prov¢d very successful and additional CADD pumps, a bladder and cardiac monitors have been purchased. The NHS Trust are refurbishing Ward 9, so temporarily the unit has been movcd to Parkside. Ivhilst the alterations are being carried out the conversion of the bathroom to a shower room that the MLGS aged to fund should be completed. Financial pressure can be a burden for some patients and the Group has established a FIardship fund to which patients can apply for assistance through the nursing team. l-he Musgrove Leukaemic Group continuc to sponsor a pool car to enable th¢ hematology iiurses to provide chemothernpy to patients in Brtdgwater and Wellington hospAtals, In the prior year, two ycars, worth of expense was paid in advance. The appointment of Icelly Savva as a reflexologist on Ward 9 has been well received by the patients. The sponsorship of that post and the partial salary support of the nurse practitioner are ongoing projects that the Group support. Fimds are held to support these projects and any other project that falls within our constitution to enable the Taunton and Somerset NHS Foundation Trust to meet the needs of the patients. I would like to thIk the officers and committee members for their continued commitment. Tricia Reed Chairperson
IVIUSGROVE LEUKAII MIC GROUP SOMEI RSET Raising funds for the benefit of PY4tients in So]nerset TRUSTEES ANNUAL REPORT VOR THK YEI AR ENDED 28 FEBRUARY 2025 (continued) ConsulÉanÉ s Report Welcome to all and I am pleased to report that the MLGS continues lo strengthen. While the NHS is always under pressure often asked to deliver more than is realistically capable of, it is reassuring to know that the people of Somerset and former patients continue to support our endeavours to help deliver the best possible service for our haemato-oncology patients. The patient feedback surveys report excellent high standards which the department is very proud of. Since last year the department has seen stable staffing levels and been able to keep up with the demands of the ever increasing service. I am very grateful to the all the staff- doctors, nurses and allied health professionals- for their on-going commitments. This has been aided in significant part to the generosity of the MLGS. The revolution in haematology and cancer drngs shows no sign of abating with ongoing less toxic trcatments continuing to be developed and made available on the NHS. Terminal diagnoses have now in many CeS become chronic long-lived conditions or highly curable. Patients who were too 'unfit' for the toxic treatments now have options to improve longevity and quality of life. The MLGS continues to be financially very secure and able to offer many improvements to assist in patient care: Further furbi8l]met of the Day Unit with new reclining chairs has continued. Thc ambulatory care unit is now fully operational - a long time in gestation requiring significant convincing of the trust management- providing paticnts a chancc to reduce inpatient stays. We are proud to have helped refurbish the unit and provide equipment for this. The most successful innovation is the development of the hardship fund - available to all our patients who would receive grants to bc cligiblc for funds to use for travel for appointments for treatment or travel to their transplant centre. This considerably reduced the stress for paticiit who struggle financially and due to illness are not able to go back to work, Your generosity has enabled a reflexologist to attend Ward 9 weekly and provide complimentary therapy to patients The conve10n of the old bathroom on Ward 9 has provided a wet room and toilet As part of our exoiting new project regarding prehabilitation of patients with acute leukaemia we have been able to purcbase 7p measure to allow fitness assessment, I once again am overwhelmed by the generosity of the local population with all the donations as well as the time and eft'ort of fund raising. The department remains indebted to have the support of the MLGS and we will continue to treat our patients with the best care and dignily available. Deepak Mannari Consultant Haematology 16 May 2025.
I[usGROVE LKUKAElVItC CROUP SOMKRSET Raising fullds for the benefit of Patients in Somerset TRUSTEES ANNUAL REPORT FOR THE YEAR ENDED 28 FEBRUARY 2025 (continued) FINANCIAL REVIEW Treasurers Reporl th The total raised for the year ended 28 February 2025 amounted to £54,609. th The total expenditure for the year ended 28 Febnwy 2025 is £95,196. The total raised since fonnation as at the 28th of Febnw 2025 is £4,131,806. The year ending FebrLLqry 2025 has seen a level of fundraising that reflects the Groups limited ability to generate funds. Unfortunately, this will become the norm going forward, therefore the continued support of our regular contributors, donors, and friends plus the dedlcated work of the Trnstees and Members is essential to enabIe the Group to continue to support projects at Musgrove Park Hospital. The Trustees, m¢mbers and volunteers absorb all their own expenses, so overheads are Minim and are currently under l % of fLmds Taised. The Musgrove Lcukaemic Group Somerset is in a sound financial position because of the retained funds held. Detailed accounts are attached for inspection.
MUSGROVK L4 UIL4EMIC GROUP SOMERSKT Raising funds for the beiiefit of Patiellts in Somerset TRusTEs ANNUAL REPORT FOR THE YEI AR ENDE4 D 28 FfBRUARY 2025 (continued) Reserves Policy Musgrove Leukaemic Group Somerset (MLGS) retains serVeS, and this document explains our policy. In defining this policy the Trustees have considered.. l) Income forecasts for future ye5 taking into account the reliability of each source of llicome and the potential for securing new income from alternative sources. 2) Expenditure forecasts for fLrture years. 3) The need to bold reserves should a medical breakthrough neccssitatc the urgent purchase of n¢w equipment. 4) The need to hold reserves to meet our immediate commitments should income levels drnsticdly fall. The Group attempts to maintain reserves of approximately £200,000, which is represented by cash on short-term dcposit and ill thc Group bank accounts. The present level of retained funds results from several legacies received in the financial year ending 2022, it is not the trustees intention to hold these funds as reserves. The Group believes it is prndent to keep this level of surpIus to: l) Ensure the Group can maintain its commitment to fund research salaries and consumablcs for year periods and to be able to so even if income levels should substantially 'fall for a period sufficient to allow alternativ¢ arnngcmcllts to be made. 2) To provide equipment on urgent request if the need should arise. 3) To act as a buffer against any unforeseen eventuality. Our levels of reserves are constantly monitored and reviewed both at Group meetings and Comrnittee meetings. The present level of Reserves is considered appropriate to enable the Group to meet our commitments for the financial year elldillg 2026. The legacies received in 2022 has resulted in the Musgrove Leukaemic Oroup Somerset being in a strong financial position. Bernrd Reed Hon. Treasurer.
MUSGROVE LEUKAEMIC GROUP SOMEI RSET Raising tunds for the benefit of Patients in Somerset TRUSTEES AI¥I¥UAL Rf4 PORT FOR THE YEAR ENDED 28 FEBRUARY 2025 (Continued) Trustees, anllual report The Musgrove Leukaemic Group Somerset (MLGS) was fomied in April 1978 by parents whose children wwe undergoing treatment for leukaemia. Due to the limited facilities at Musgrove Park Hospital they had to visit hospitals in Southampton and Bristol for treatment, placing severe strain on the families, The present Trustees are a group of people continuing to fLU]draise to improve the facilities for leukaemia and lymphoma patients and their families in Somerset. The funds raised by the MLGS are utilised to purchases equipment for the wards to improve the experience of patients whilst undergoing treatmcnt. The MLGS has now raised over £4 Million, 95 % of which has/is being made available to Musgrove Park Hospitals, Haematologyloncology and Children's Unit becausc all the TTUSte¢s and members services are voluntary. The Trustees will work with the medical team to provide facilities to improve the patient experience whilst they arc reIVing treatment. The funds are raised by various means but principally from donations including legacics, collections, and other fundraising evcnts. Our aim is to contillue to raise funds to improve the hospital experience for leukaemia and lymphoma patients.
MUSGROVE LEUKAEMIC GROUP SOMERSEI T Raising funds for the benefit of Patients in Somerset TRUSTKES ANNUAL REPORT FOR TH1 YEAR ENDED 28 FEBRUIIRY 2025 (continued) STATEIVIENT OF TRUSTfES RLSPONSIBILITIES Cbarity law requires the trust¢es to prepare financial statements for each financial year which show a true and fair view of the state of affairs of the charity and its financial activities for that period. In preparing those financial statements, the trustees are required to Select suitable accounting policies and then apply thern consistently" Make judg¢ments and estimates that are reasonable and prudent. stste whether applicable accounting standards and statements of recommended practice have been followed, subject to ally departure disclosed and explained in the financial statements, and Prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in operational existence. The Trustees are responsible for keeping proper accounting records whAch disclose with reasonable accuracy at any tin)c the financial position of the charity and to enable them to ensure that the financial statements comply with the Charities Act 2011. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. DECLARATION The Trustees declare that they have approved the Trnstees, Report. Signed on behalf of the charity's trustees,, Tricia Reed Chair
IvtUSGROVE LLUKAKMIC GROUP SOMERSET Raising funds for the benefit of l>atients in Somerset Independent Examiner's Report to tbe Trustees of Musgrove Leukaemic Group Somerset I report on the accounts of Musgrove Leukaemic Group Somerset for the year ended 28 February 2025 which are set out on pages 9 to 13. Respective responsibilities of trnstees and examiner The charity's trustees are responsible for the preparation of the accounts. The charity's trustees consider that an audit is not required for this year under section 144 of the Clmrities Act 2011 (the Charities Act) and that an independent examination is needed, It is my responsibility to: examine the accounts under section 145 of the Charities Act. to follow the procedures laid down in the general Directions given by the Charity Commissioncrs (under section 145 (5) (b) of the Charities Act). and to state whether particular matters have come to my attention. Basis of independent examiner's report My examination was carricd out in accordanc¢ with the generaI Directions given by the Charity Commission. An exarnination includes a review of the accounting records kept by th6 charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts and sccking explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in all audit, and consequently no opinion is given as to whether the accounts present a 'ITue and .fair' view and the report is limited to those Matte set out in the statement bclow. Independent exa]niner's statement In connection with my exatnination, no matter has come to my attention: i) which gives tlle reasonable cause to believe that in, any material respect, the requirements to keep accounting records in accordance with section 130 of the Charities Act; and to prepare accounts which accord with the accounting records and comply with the accounting requirements ot. the Chariti¢s Act have not bccn mc: or 2) to wljich, in my opinion, attention should be drawn in order to enable & proper understanding of the accouiits to be reached. Mark Powell Moiiahans 6 ' Floor Whilefriars Lewins Mead Bristol BSI 2NT Date:
IIIUSGROVE LLUKAEMIC CROUP SOMERSET Raising fullds for the benefit of Patients in Somerset STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEI AR ENDED 28 FBRUARy 2025 Unrestricted Restricted Total Funds Total Funds Funds Funds 2025 2024 INCOME & EXPENDITURE Inco]nillg Ilesources Donations, legacies and similar incoming resources; Donations Fund Raising Collections Covenants & Gift Aid (including tax recovered) 12,043 6,355 1,142 12,043 6,355 1,142 10,671 8,242 1,558 1,920 1,920 2,405 Investment Income: Bank Interest 33,149 33,149 24,938 TOTAL INCOMING RESOURCES 54,609 54,609 47,814 Resources xpended Note Direct Charitable Expenditure Fund Raising and Publicity Management alld Administration 93,425 681 93,425 681 24,743 209 1,090 1,090 986 TOTAL RESOURCES EXPENDED 95,196 95,196 25,938 NET (OUT)/INFLOW OF RESOURCES FOR THE YEAR AND MOVEMENT IN FUNDS (40,587) (40,587) 21,876 Balance brought forward at l March 2024 911,269 911,269 889,393 BALANCES CARRIED FORWARD AT 28 FEBRUARY 2025 870,682 870,682 911,269 10
MUSGROVE LLUKALMIC GROUP SOMERSET Raising funds for the benefit of Patients in Somerset BALANCE SHE1 T AS AT 28 BRUARy 2025 2025 2024 Note CURRENT ASSETS Debtors Short term deposits Cash at bank and in hand 623 800,000 114,174 722 750,000 160,967 914,797 911,689 CREDITORS: Amounts falling due within one year 44,115 420 TOTAL IYET ASSETS 870,682 911,269 Funded by: UNR1 STRICTED FUNDS Gencral Fund 870,682 911,269 These accoimts approved by the TneS on. ./1,. ernard Reed Treasurer For and on behalf of tbe Trustees Jane Allin Secretary 11
MUSGROVEI LEUKAEMIC GROUP SOMEI RS[I T Raising funds lor the benefit of Patiellts ill Somerset NOTES TO THE ACCOUNTS FOR THE YEAR ENDKD 28 FEBRUARY 2025 ACCOUNTING POLICIES Accounting basis and standards The financial statements have been prepared under tbe historical cost convention and in accordance with applicable accounting standards, the Charities SORP (FRS102) (Accounting and Reporting by ChtleS) and comply with the Charities (Accounts and Reports) Regulations 2008 issued under the Charities Act 2011. Voluntary Income Voluntary income is received from a numbcr of sources, including donations, collections and other fund raising events. Such income is included in full in the income and expenditure account wh¢n received. Restricted and Unrestricted Fllnds Where appropriate, the accounts distingllish between restrACted and unrestricted funds. The fonner are received from dollo and are subject to restrictions on the purpose for which they may be used. U]]restiicted funds are thos¢ where there are no externally imposed restrictions which the charity may use at its discretion to achieve its objectives. In the opinion of the Officws the Charity does not operate any restricted funds. d) Short Term Deposits Short term deposits represent monies placed on deposit with National Westminstcr Bank Tasury Reserve Centre. Bank Interest Bank Interest is credited to the incorne and expenditure account when received. Covenants Covenants are credited to the income and expenditure account when received. Provision is made foi, recoverable income tax arising from the covenants. 12
IkWSGROVE LEUKAEMIC GROUP SOMKRSKT Raising funds for the benefit of Patlents in Somerset NOTES TO THE ACCOUNTS FOR THEI YEAR NDKD 28 FEBRUARY 2025 (Continued) Taxation Musgrove Leukaemic Group Somerset is a registered Charity and the results of its normal activities are not liable to cooration tax. Unrestricted Restricted Total Funds Total Funds Funds Funds 2025 2024 DIRECT CHARITABLE EXPENDITURE (Amounts payable in furtherance of the Charities obj ects): Clinical unit grants Complimentary medicine grants Chemotherapy pool car grant 90,245 3,180 90,245 3,180 19,259 5,484 93,425 93,425 24,743 T'he above grnnts were made in support of Musgrove Park Hospital in Taunton. FUND RAISIIYG AND PUBLICITY Fund raising costs Publications 480 201 480 201 209 681 681 209
MUSGROVL L1 UKAEMIC GROUP SOMERSET Raising funds for the benefit of Patients in Somerset NOTEI S TO THE ACCOUNTS FOR THE YEAR NDD 28 FEBRUARY 2025 (Continued) Unrestricted Restricted Total Funds Total Funds Funds Funds 2025 2024 MANAGEMENT AND ADMINISTRATION OF CHARITY Public liability insurance Independent examiners fees Letterhead paper 580 480 30 580 480 30 566 420 1,090 1,090 986 DEBTORS Income tax recoverable 623 722 CRfi DITORS: Amounts falling due within one year Accountancy accrual Clinical unit grants accrual 450 43,665 420 44,115 420 Balance Net movement Balance 1.3.24 funds 28.2.25 UNRESTRICTED FUNDS General Fund 911,269 (40,587) 870,682 14